ClinConnect ClinConnect Logo
Search / Trial NCT07087184

Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jul 18, 2025

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Cardiovascular Disease Milk Fat Milk Dairy Products Insulin Resistance Hyperlipidemia

ClinConnect Summary

This clinical trial is looking at how drinking different types of milk—whole milk (which has more fat) versus skim milk (which has little to no fat)—affects heart health and blood sugar control. Since heart disease is a leading cause of death, understanding whether the fat in milk changes risks like cholesterol levels or insulin resistance (how well your body handles sugar) could help guide better dietary advice. The study will have participants switch between drinking whole milk and skim milk while tracking changes in their blood fats and sugar levels.

To join, you need to be 18 or older, drink at least one cup of dairy milk most days, and have a smartphone to use the study’s app. People who are lactose intolerant, have had a heart attack or diabetes, or have certain cholesterol conditions won’t be able to join. If you participate, you’ll be asked to drink only one type of milk for a period, then switch to the other type, while the study collects information through the app. This research could help clarify whether low-fat or full-fat milk is better for heart and metabolic health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Are age ≥18 years
  • Have a smartphone
  • Are able to use the Eureka mobile application
  • Consume, on average, at least one cup of dairy milk daily, at least 5 days per week
  • Exclusion Criteria:
  • Non-English speaker
  • Are lactose intolerant
  • History of myocardial infarction
  • History of type I or type II diabetes
  • Familial hypercholesterolemia
  • Plan to change treatment for cholesterol
  • Unable to read or sign to provide informed consent

About University Of California, San Francisco

The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.

Locations

San Francisco, California, United States

Patients applied

0 patients applied

Trial Officials

Gregory M Marcus, MD, MAS

Principal Investigator

University of California, San Francisco

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported